Literature DB >> 33946480

Cancer Stem Cells and Neovascularization.

Fengkai Li1,2,3, Jiahui Xu1,2,3, Suling Liu1,2,3.   

Abstract

Cancer stem cells (CSCs) refer to a subpopulation of cancer cells responsible for tumorigenesis, metastasis, and drug resistance. Increasing evidence suggests that CSC-associated tumor neovascularization partially contributes to the failure of cancer treatment. In this review, we discuss the roles of CSCs on tumor-associated angiogenesis via trans-differentiation or forming the capillary-like vasculogenic mimicry, as well as the roles of CSCs on facilitating endothelial cell-involved angiogenesis to support tumor progression and metastasis. Furthermore, we discuss the underlying regulation mechanisms, including the intrinsic signals of CSCs and the extrinsic signals such as cytokines from the tumor microenvironment. Further research is required to identify and verify some novel targets to develop efficient therapeutic approaches for more efficient cancer treatment through interfering CSC-mediated neovascularization.

Entities:  

Keywords:  angiogenesis; cancer stem cells; therapeutic strategies; vascular mimicry

Year:  2021        PMID: 33946480     DOI: 10.3390/cells10051070

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  79 in total

Review 1.  Oxygen(es) and the hypoxia-inducible factor-1.

Authors:  R H Wenger; M Gassmann
Journal:  Biol Chem       Date:  1997-07       Impact factor: 3.915

2.  Nodal signaling activates the Smad2/3 pathway to regulate stem cell-like properties in breast cancer cells.

Authors:  Wenchen Gong; Baocun Sun; Huizhi Sun; Xiulan Zhao; Danfang Zhang; Tieju Liu; Nan Zhao; Qiang Gu; Xueyi Dong; Fang Liu
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

3.  Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway.

Authors:  Vesselina G Cooke; Valerie S LeBleu; Doruk Keskin; Zainab Khan; Joyce T O'Connell; Yingqi Teng; Michael B Duncan; Liang Xie; Genta Maeda; Sylvia Vong; Hikaru Sugimoto; Rafael M Rocha; Aline Damascena; Ricardo R Brentani; Raghu Kalluri
Journal:  Cancer Cell       Date:  2012-01-17       Impact factor: 31.743

Review 4.  ALDH as a Stem Cell Marker in Solid Tumors.

Authors:  Mariel E Toledo-Guzmán; Miguel Ibañez Hernández; Ángel A Gómez-Gallegos; Elizabeth Ortiz-Sánchez
Journal:  Curr Stem Cell Res Ther       Date:  2019       Impact factor: 3.828

5.  Different roles of TGF-β in the multi-lineage differentiation of stem cells.

Authors:  Ming-Ke Wang; Hui-Qin Sun; Ying-Chun Xiang; Fan Jiang; Yong-Ping Su; Zhong-Min Zou
Journal:  World J Stem Cells       Date:  2012-05-26       Impact factor: 5.326

6.  Focal adhesion kinase promotes the aggressive melanoma phenotype.

Authors:  Angela R Hess; Lynne-Marie Postovit; Naira V Margaryan; Elisabeth A Seftor; Galen B Schneider; Richard E B Seftor; Brian J Nickoloff; Mary J C Hendrix
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

7.  VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry.

Authors:  Angela R Hess; Elisabeth A Seftor; Lynn M Gruman; Michael S Kinch; Richard E B Seftor; Mary J C Hendrix
Journal:  Cancer Biol Ther       Date:  2006-02-14       Impact factor: 4.742

Review 8.  Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry.

Authors:  Elisabeth A Seftor; Paul S Meltzer; Gina C Schatteman; Lynn M Gruman; Angela R Hess; Dawn A Kirschmann; Richard E B Seftor; Mary J C Hendrix
Journal:  Crit Rev Oncol Hematol       Date:  2002-10       Impact factor: 6.312

9.  A novel endothelial-specific membrane protein is a marker of cell-cell contacts.

Authors:  M G Lampugnani; M Resnati; M Raiteri; R Pigott; A Pisacane; G Houen; L P Ruco; E Dejana
Journal:  J Cell Biol       Date:  1992-09       Impact factor: 10.539

10.  Stem-like Human Breast Cancer Cells Initiate Vasculogenic Mimicry on Matrigel.

Authors:  Yuki Izawa; Karin Kashii-Magaribuchi; Kana Yoshida; Mayu Nosaka; Nanami Tsuji; Ai Yamamoto; Kana Kuroyanagi; Kanoko Tono; Misato Tanihata; Moe Imanishi; Momoka Onishi; Mayu Sakiyama; Sana Inoue; Rei Takahashi
Journal:  Acta Histochem Cytochem       Date:  2018-12-15       Impact factor: 1.938

View more
  5 in total

1.  The Anti-Colon Cancer Effects of Essential Oil of Curcuma phaeocaulis Through Tumour Vessel Normalisation.

Authors:  Yewen Feng; Lu Deng; Hengrui Guo; Yumin Zhao; Fu Peng; Gang Wang; Chenghao Yu
Journal:  Front Oncol       Date:  2021-10-26       Impact factor: 6.244

2.  Silencing PLOD2 attenuates cancer stem cell-like characteristics and cisplatin-resistant through Integrin β1 in laryngeal cancer.

Authors:  Meiyan Song; Xing Liu; Tao Li; Yueqin Zhang; Xiaoyan Zhao; Wen Sun; Zhen Li
Journal:  Transl Oncol       Date:  2022-06-03       Impact factor: 4.803

Review 3.  Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review.

Authors:  Riccardo Di Fiore; Sherif Suleiman; Rosa Drago-Ferrante; Yashwanth Subbannayya; Francesca Pentimalli; Antonio Giordano; Jean Calleja-Agius
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

Review 4.  Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches.

Authors:  Nehad M Ayoub; Sara K Jaradat; Kamal M Al-Shami; Amer E Alkhalifa
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

5.  Crosstalk of Redox-Related Subtypes, Establishment of a Prognostic Model and Immune Responses in Endometrial Carcinoma.

Authors:  Rui Geng; Jiahang Song; Zihang Zhong; Senmiao Ni; Wen Liu; Zhiqiang He; Shilin Gan; Qinghao Huang; Hao Yu; Jianling Bai; Jinhui Liu
Journal:  Cancers (Basel)       Date:  2022-07-12       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.